Pharmacology, Toxicology and Pharmaceutical Science
Placebo
73%
Typical Antipsychotic
54%
Nootropic Agent
54%
Aripiprazole
50%
Paliperidone
43%
Olanzapine
43%
Positive Syndrome
39%
Negative Syndrome
36%
Brain Atrophy
33%
Randomized Controlled Trial
33%
Tolerability
33%
Alzheimer's Disease
33%
Minocycline
33%
Brexpiprazole
33%
Lamictal
33%
Oxytocin
33%
Topiramate
33%
Remission
33%
Antipsychotic
33%
Mild Cognitive Impairment
33%
Cognitive Defect
33%
Quetiapine
30%
Lorazepam
16%
Levomepromazine
16%
Clozapine
16%
Risperidone
16%
Adverse Event
13%
Donepezil
12%
Rivastigmine
12%
Depression
8%
Controlled Clinical Trial
8%
Symptom
8%
Clocapramine
6%
Clospipramine
6%
Perospirone
6%
Extrapyramidal Symptoms
6%
Keyphrases
Alzheimer's Disease
33%
Systematic Meta-analysis
33%
Comparative Efficacy
33%
Comparative Safety
33%
Memantine
33%
Meta-analysis
33%
Network Meta-analysis
33%
Lamotrigine
33%
Enrichment Design
33%
Brexpiprazole
33%
Relapse Prevention
33%
Recent-onset
33%
Aripiprazole Once-monthly
33%
Oxytocin Augmentation
33%
Topiramate
33%
Acetylcholinesterase Inhibitors (AChEI)
25%
Standardized Mean Difference
19%
Confidence Interval
19%
Quetiapine
13%
Cognitive Function Assessment
11%
Disturbance Scores
11%
Behavioral Disturbances
11%
Rapid Cycling
11%
Intellectual Functioning
9%
CGI-I
8%
CGI-S
8%
S-score
8%
Third-line Treatment
8%
Placebo
8%
Sensitivity Analysis
8%
Individual Risk
6%
Perospirone
6%
Bayesian Analysis
6%
Efficacy Data
6%
Safety Outcomes
6%
Clinical Decisions
6%
Homogeneous Groups
6%
Current Analysis
6%
Risk Expectations
6%
All-cause Discontinuation
5%
Oxytocin Administration
5%
Patient's Sleep
5%
Sleep Satisfaction
5%
Wake Time after Sleep Onset
5%
Insomnia Treatment
5%
Neuroscience
Meta-Analysis
100%
Placebo
77%
Dementia Praecox
66%
Alzheimer's Disease
66%
Memantine
33%
Mild Cognitive Impairment
33%
Treatment of Schizophrenia
33%
Suvorexant
33%
Oxytocin
33%
Cognitive Function
23%
Negative Syndrome
19%
Positive Syndrome
14%
Quetiapine
13%
Behavior Disorder
11%
Donepezil
11%
Acetylcholinesterase Inhibitor
11%
Sleep Time
11%
Headache
10%
Randomized Controlled Trial
9%
Wechsler Adult Intelligence Scale
8%
Rivastigmine
8%
Prolactin
7%
Extrapyramidal Symptoms
6%
Somnolence
5%
Nightmare
5%
Major Depressive Disorder
5%